Ikena Oncology, Inc. (IKNA) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.
The consensus price target is $1.33, representing a downside of 92.2% from the current price $17.16.
IKNA Stock — 12-Month Price Forecast
$1.33
▼ -92.25% Downside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Ikena Oncology, Inc., the price target is $1.33.
The average price target represents a -92.25% change from the last price of $17.16.
IKNA Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Ikena Oncology, Inc. in the past 3 months
